Patents by Inventor Jerome Smith

Jerome Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240344061
    Abstract: The present invention provides agents and compositions for modulating expression (e.g., enhanced or reduced expression) of a hepatocyte nuclear factor 4 alpha (HNF4?) gene by targeting an HNF4? expression control region and methods of use thereof for treating an HNF4? associated disorder, e.g., cirrhosis.
    Type: Application
    Filed: April 17, 2024
    Publication date: October 17, 2024
    Applicant: Omega Therapeutics, Inc.
    Inventors: Jesse Jerome Smith, Jodi Michelle Kennedy, Jeremiah D. Farelli, Kendrick Alan Goss, Adam Walter Scheidegger, Yoseph Kassa, Christian Wessel Cobaugh, Timsi Rao
  • Publication number: 20240296188
    Abstract: A method for parsing a document having a document type, where the document type has a corresponding type structure including a plurality of document components, comprising receiving a new document, determining the document type, and selecting a parser from a plurality of parsers based on the document type. The method continues with parsing the document into a tagged data structure using the selected document parser, where the tagged data structure corresponds to the type structure of the document. The populated tagged data structure is stored in a database and made available over a computer network. In some embodiments, the document converted to simplified XML prior to parsing.
    Type: Application
    Filed: December 21, 2021
    Publication date: September 5, 2024
    Inventors: Trevor Jerome SMITH, Umair RAFIQ
  • Patent number: 11987791
    Abstract: The present invention provides agents and compositions for modulating expression (e.g., enhanced or reduced expression) of a hepatocyte nuclear factor 4 alpha (HNF4?) gene by targeting an HNF4? expression control region and methods of use thereof for treating an HNF4? associated disorder, e.g., cirrhosis.
    Type: Grant
    Filed: September 23, 2020
    Date of Patent: May 21, 2024
    Assignee: Omega Therapeutics, Inc.
    Inventors: Jesse Jerome Smith, Jodi Michelle Kennedy, Jeremiah D. Farelli, Kendrick Alan Goss, Adam Walter Scheidegger, Yoseph Kassa, Christian Wessel Cobaugh, Timsi Rao
  • Publication number: 20240018522
    Abstract: Described herein are oligonucleotides (e.g., single-stranded oligonucleotides) and compositions thereof for targeting a mutation in the spliceosome, such as the U 1 small nuclear RNA (snRNA), as well as related methods of use.
    Type: Application
    Filed: October 26, 2021
    Publication date: January 18, 2024
    Inventors: Jesse Jerome Smith, Duncan Brown, Michael W. Seiler, Peter Smith, Anant A. Agrawal
  • Publication number: 20230374549
    Abstract: The present disclosure relates to site-specific disrupting agents for modulating, e.g., decreasing, expression of a target plurality of genes in a cell. In some embodiments, the target plurality of genes comprises pro-inflammatory genes, e.g., CXCL1, CXCL2, CXCL3, CXCL4, CXCL5, CXCL6, CXCL7, and IL-8. In some embodiments, the method comprises using a first site-specific disrupting agent that targets a first anchor sequence and a second site-specific disrupting agents that disrupts a second anchor sequence.
    Type: Application
    Filed: September 29, 2021
    Publication date: November 23, 2023
    Inventors: Lauren Marie BEECH, Jesse Jerome SMITH, Rahul KARNIK, Kendrick Alan GOSS, Adam Walter SCHEIDEGGER, Jodi Michelle KENNEDY, Jeremiah Dale FARELLI, Houda BELAGHZAL, Laura Anh NGUYEN, Charles W. O'DONNELL
  • Publication number: 20220348893
    Abstract: The present disclosure relates generally to methods and compositions for modulating frataxin (FXN) expression, e.g., to treat Friedreich ataxia (FRDA).
    Type: Application
    Filed: September 23, 2020
    Publication date: November 3, 2022
    Inventors: Serena Lunardi, Adam Walter Scheidegger, Jesse Jerome Smith, Jeremiah Dale Farelli, Jodi Michelle Kennedy
  • Publication number: 20220348908
    Abstract: The present invention provides agents and compositions for modulating expression (e.g., enhanced or reduced expression) of a hepatocyte nuclear factor 4 alpha (HNF4a) gene by targeting an HNF4? expression control region and methods of use thereof for treating an HNF4? associated disorder, e.g., cirrhosis.
    Type: Application
    Filed: September 23, 2020
    Publication date: November 3, 2022
    Inventors: Jesse Jerome Smith, Jodi Michelle Kennedy, Jeremiah D. Farelli, Kendrick Alan Goss, Adam Walter Scheidegger, Yoseph Kassa, Christian Wessel Cobaugh, Timsi Rao
  • Publication number: 20220288237
    Abstract: The present invention provides agents and compositions for modulating expression (e.g., enhanced or reduced expression) of an apolipoprotein B (APOB) gene by targeting an APOB expression control region and methods of use thereof for treating an APOB associated disorder, e.g., hypercholesterolemia.
    Type: Application
    Filed: March 22, 2022
    Publication date: September 15, 2022
    Applicant: Omega Therapeutics, Inc.
    Inventors: Vishwesh Ashok Patil, Jeremiah D. Farelli, Rahul Karnik, Jesse Jerome Smith, Can Sarisozen, Adam Walter Scheidegger, Barbara Bennett
  • Publication number: 20210208168
    Abstract: Methods, kits and devices for detecting antineoplastic drug contamination of a surface are provided according to aspects of the present invention. According to aspects of the invention, methods for detecting antineoplastic drug contamination of a surface include providing a wetting solution compatible with the antineoplastic drug and formulated to promote release of the drug from the surface to be assayed; providing a solid matrix for reversible absorption of the antineoplastic drug; contacting the solid matrix with the wetting solution, generating an assay matrix; contacting the assay matrix and the surface, generating a surface sample; contacting the surface sample with a volume of wetting solution, generating a fluid test sample; and quantifying the antineoplastic drug in the fluid test sample by lateral flow assay to produce an assay result, thereby detecting antineoplastic drug contamination of the surface.
    Type: Application
    Filed: August 17, 2020
    Publication date: July 8, 2021
    Inventors: Jerome Smith, Deborah Sammons, Shirley Robertson
  • Patent number: 10782308
    Abstract: Methods, kits and devices for detecting antineoplastic drug contamination of a surface are provided according to aspects of the present invention. According to aspects of the invention, methods for detecting antineoplastic drug contamination of a surface include providing a wetting solution compatible with the antineoplastic drug and formulated to promote release of the drug from the surface to be assayed; providing a solid matrix for reversible absorption of the antineoplastic drug; contacting the solid matrix with the wetting solution, generating an assay matrix; contacting the assay matrix and the surface, generating a surface sample; contacting the surface sample with a volume of wetting solution, generating a fluid test sample; and quantifying the antineoplastic drug in the fluid test sample by lateral flow assay to produce an assay result, thereby detecting antineoplastic drug contamination of the surface.
    Type: Grant
    Filed: July 16, 2013
    Date of Patent: September 22, 2020
    Assignee: THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION
    Inventors: Jerome Smith, Deborah Sammons, Shirley Robertson
  • Patent number: 9507769
    Abstract: Computer-implemented methods can transform a corpus of meaningful text sequences into a generalized computer-usable repository of neurolinguistic information that can be applied by one or more computer systems. The computer system(s) can use the neurolinguistic information to neurolinguistically analyze meaningful text sequences to derive statistical information and identify dominant cognitive motivation orientations expressed in those text sequences. The identified dominant cognitive motivation orientations can be used to improve the efficacy of both human-generated and machine-generated communications. The computer system(s) thereby transform a meaningful text sequence into actionable information about the dominant cognitive motivation orientation(s) of the author of that text sequence within the context in which the text sequence was composed. Computer systems and computer-program products for implementing the methods are also described.
    Type: Grant
    Filed: January 27, 2016
    Date of Patent: November 29, 2016
    Assignee: Weongozi Inc.
    Inventors: Shelle Rose Charvet, Michael Horst Tschichholz, Stephan Busemann, Jorg Steffen, Jonathan Scott Rose, Peter Jerome Smith
  • Publication number: 20160239478
    Abstract: Computer-implemented methods can transform a corpus of meaningful text sequences into a generalized computer-usable repository of neurolinguistic information that can be applied by one or more computer systems. The computer system(s) can use the neurolinguistic information to neurolinguistically analyze meaningful text sequences to derive statistical information and identify dominant cognitive motivation orientations expressed in those text sequences. The identified dominant cognitive motivation orientations can be used to improve the efficacy of both human-generated and machine-generated communications. The computer system(s) thereby transform a meaningful text sequence into actionable information about the dominant cognitive motivation orientation(s) of the author of that text sequence within the context in which the text sequence was composed. Computer systems and computer-program products for implementing the methods are also described.
    Type: Application
    Filed: January 27, 2016
    Publication date: August 18, 2016
    Inventors: Shelle Rose Charvet, Michael Horst Tschichholz, Stephan Busemann, Jorg Steffen, Jonathan Scott Rose, Peter Jerome Smith
  • Patent number: 9268765
    Abstract: Computer-implemented methods can transform a corpus of meaningful text sequences into a generalized computer-usable repository of neurolinguistic information that can be applied by one or more computer systems. The computer system(s) can use the neurolinguistic information to neurolinguistically analyze meaningful text sequences to derive statistical information and identify dominant cognitive motivation orientations expressed in those text sequences. The identified dominant cognitive motivation orientations can be used to improve the efficacy of both human-generated and machine-generated communications. The computer system(s) thereby transform a meaningful text sequence into actionable information about the dominant cognitive motivation orientation(s) of the author of that text sequence within the context in which the text sequence was composed. Computer systems and computer-program products for implementing the methods are also described.
    Type: Grant
    Filed: April 18, 2013
    Date of Patent: February 23, 2016
    Assignee: Weongozi Inc.
    Inventors: Shelle Rose Charvet, Michael Horst Tschichholz, Stephan Busemann, Jorg Steffen, Jonathan Scott Rose, Peter Jerome Smith
  • Publication number: 20150037522
    Abstract: Disclosed is a decorative cover for cleaning product containers. The device includes a cylindrical cover having a decorative ornamentation on its exterior surface. In some embodiments, the cover may also include decorative ornamentation on its interior surface to provide fluidity of content and design. The ornamentation is customizable so that the cover may be decorated with any pattern, image, or inscription. The cover has an open top and bottom configuration so as to allow a user to slide on the cover over an existing cleaning product container without requiring additional attachment means. The device is constructed to conceal the basic packaging disposed on the product containers. In this way, the present invention adds a decorative appeal to an otherwise basic packaging which may not be aesthetically appealing to consumers.
    Type: Application
    Filed: June 5, 2014
    Publication date: February 5, 2015
    Inventor: Jerome Smith
  • Publication number: 20140017812
    Abstract: Methods, kits and devices for detecting antineoplastic drug contamination of a surface are provided according to aspects of the present invention. According to aspects of the invention, methods for detecting antineoplastic drug contamination of a surface include providing a wetting solution compatible with the antineoplastic drug and formulated to promote release of the drug from the surface to be assayed; providing a solid matrix for reversible absorption of the antineoplastic drug; contacting the solid matrix with the wetting solution, generating an assay matrix; contacting the assay matrix and the surface, generating a surface sample; contacting the surface sample with a volume of wetting solution, generating a fluid test sample; and quantifying the antineoplastic drug in the fluid test sample by lateral flow assay to produce an assay result, thereby detecting antineoplastic drug contamination of the surface.
    Type: Application
    Filed: July 16, 2013
    Publication date: January 16, 2014
    Inventors: Jerome Smith, Deborah Sammons, Shirley Robertson
  • Publication number: 20070142525
    Abstract: Provided is a composition comprising 20 to 60 weight % of a reduced oxide of a metal selected from the group consisting of Mo, Nb, Cr and Ti, 1 to 9 weight % of a carbon allotrope and a polymer binder. A process for making a polymeric resistor having low temperature of resistance comprising mixing a polymer binder with the provided composition.
    Type: Application
    Filed: December 16, 2005
    Publication date: June 21, 2007
    Inventors: Nyrissa Rogado, Munirpallam Subramanian, Jerome Smith
  • Publication number: 20070136763
    Abstract: The TNT Datamaster and Beyond is a machine that incorporates all copying, duplication and transference recording conversion needs into one 60+? or smaller unit. This product feature serves as a transaction computer, initial Internet base televisual blend classification to form a more enhanced digital transference device/personal recording studio. Using convenient performance/function keys, users can automatically copy their old music and videos onto unlimited hard drive space, CDs or DVDs. It also offers a turntable part to copy vinyl and computer connections for peripherals. It allows you to have your standard mixing CPU with CD-ROM-DVD ROM, Audiocassette, VCR, Turntable and 8-Track etc. You can transfer all data. Cassette Tapes easily break and you can lose songs that are hard to find that you may have had only on tape and this is good because cassette tapes are becoming obsolete.
    Type: Application
    Filed: August 10, 2006
    Publication date: June 14, 2007
    Inventors: La Tretha Stroughter, Jerome Smith
  • Publication number: 20060266984
    Abstract: This invention is directed to black conductive compositions, black electrodes made from such compositions and methods of forming such electrodes. In particular, the invention is directed to a single layer bus electrode.
    Type: Application
    Filed: May 4, 2006
    Publication date: November 30, 2006
    Inventors: Ji-Yeon Lee, Michael Barker, Keiichiro Hayakawa, Hisashi Matsuno, Hiroaki Noda, Jerome Smith
  • Publication number: 20060238503
    Abstract: Deputy Series-Music Cinema et. al. Is a televisual/satellite, mass production and communications system. Coliseum Screens are maximized in mobility as a part of our “Digi-Tasking-Mobile-Cycle”. The Coliseum Screens are two wireless/cordless detachable television/computer monitors. Multiple style tooth ray enhancements along with media to media digital interface transfer. The Arsenal Tower will generate all components. Coliseum Screens/Television monitors will reach trillions in satellite cable style interface. Equipped with scrambler/de-scrambler-tracking capabilities. All keyboards will support functions that appear on Coliseum Screens. Dust Shield Wiper capabilities for screen cleaning. My Flavorite Pen enables writing in mid air through laser to laser enhancements.
    Type: Application
    Filed: April 22, 2006
    Publication date: October 26, 2006
    Inventors: Jerome Smith, La Tretha Stroughter
  • Publication number: 20060202174
    Abstract: The invention is directed to black conductive composition(s), black electrodes made from such compositions and methods of forming such electrodes. In particular, the invention is directed to flat panel display applications, including alternating-current display panel applications. Still further, the invention is directed to composition(s) utilizing conductive metal oxides selected from an oxide of two or more elements selected from Ba, Ru, Ca, Cu, Sr, Bi, Pb, and the rare earth metals and photocrosslinkable polymers. These compositions are particularly useful in making photoimageable black electrodes for flat panel display applications.
    Type: Application
    Filed: March 7, 2006
    Publication date: September 14, 2006
    Inventors: Michael Barker, Keiichiro Hayakawa, Jerome Smith